Drugs / Netopitam Palonosetron
last change Jan 2026 re-read 3 minutes ago

Netopitam Palonosetron

Developed for
head and neck squamous cell carcinoma
Investigated by
Sichuan Cancer Hospital and Research Institute

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06102447 Nov 2023 → Jan 2026 head and neck squamous cell carcinoma Sichuan Cancer Hospital and Research Institute Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Netopitam Palonosetron ClinicalTrials.gov intervention name — accepted as the source's own label NCT06102447 ↗